Skip to main navigation Skip to search Skip to main content

Open-Label Extension Study of Setmelanotide in Patients with a Rare Genetic, Syndromic or Acquired Disease of the MC4R Pathway

Project: Research

Project Details

StatusActive
Effective start/end date11/5/24 → 12/11/26

Funding

  • Rhythm Pharmaceuticals Incorporated: $58,064.45